341.04
74,169.95
0.46%
Market Closed
-7
1,240.4
-0.56%
4.1
1,709.9
0.24%
-15.1
3,497.25
-0.43%
6.55
1,639.4
0.47%
18.1
1,268.35
1.45%
11.3
1,590.55
0.72%
-5.05
722.7
-0.69%
160.75
8,580
1.91%
-4.05
407.8
-0.98%
-4.8
2,171.05
-0.22%
5.2
745
0.57%
-5.5
3,182.9
-0.17%
11.05
1,545.6
0.58%
22.2
1,706.05
1.26%
8
1,992.8
0.46%
48.85
11,557.5
0.24%
60.7
2,704.1
2.26%
-0.1
331.6
-0.03%
23.8
1,033.95
2.36%
99.3
10,547.8
1.07%
64.9
1,871.85
3.59%
4.3
229.75
1.91%
-4.15
259.8
-1.57%
7.55
3,016.8
0.13%
30.05
2,252
1.26%
26.75
3,824.3
0.7%
-0.3
267.3
-0.19%
4.05
1,005.05
0.7%
18.3
1,137.25
1.63%
5.5
660.9
0.84%
7.5
385.8
1.98%
44.75
3,439.6
1.32%
-11.15
2,219.8
-0.5%
-17.95
2,173.9
-0.76%
-23.7
7,484.75
-0.11%
0.05
280.15
0.02%
-1.25
510.7
-0.24%
2.45
203.85
1.22%
0.95
151.8
0.63%
83.7
4,783.8
1.74%
5.45
435.3
1.27%
131.5
5,157
2.52%
15.5
4,940.55
0.03%
-1.45
124.2
-1.15%
3.8
446.75
0.86%
19.5
507.4
4%
30.4
2,399.75
1.26%
-2.35
655.65
-0.33%
1.05
118.75
0.89%
3.65
680.8
0.78%
341.04
74169.95
0.46%
Market Closed
Home|MytestPage_shyamal

CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days
The Indian Hotels Company Ltd. 24/08/2023401.85517.9007/02/2024 28.88% 167 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Biocon subsidiary to Invest USD 56 Million in Syngene USA Inc for Biologics Facility Acquisition; DIIs increased their stake in last Quarter Biocon subsidiary to Invest USD 56 Million in Syngene USA Inc for Biologics Facility Acquisition; DIIs increased their stake in last Quarter

Biocon subsidiary to Invest USD 56 Million in Syngene USA Inc for Biologics Facility Acquisition; DIIs increased their stake in last Quarter

With a PE ratio of 57.6x, the company trades at a premium compared to the industry PE of 46x. The company has ROCE of 14.7 per cent and ROE of 13.2 per cent.  

Prajwal Wakhare 0 75 Article rating: 5.0
Read more
RSS

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

SEBI Registered Research Analyst Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INH000006396
Validity: Oct 05, 2018 - Perpetual
BSE Enlistment No. 5307

SEBI Registered Investment Adviser Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INA000001142
Validity: Aug 19, 2019 - Perpetual
BSE Enlistment No. 1346

Registered Address:
419-A, 4th floor, Arun Chambers,
Tardeo, Next to AC Market, Mumbai - 400 034.
Tel: +91 022-43476012/13/14/15 | Email: service@dsij.in
CIN No.: U22120MH2003PTC139276
GST No.: 27AACCR4303G1ZP

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR

Disclaimer: "Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors"

Investment in securities market is subject to market risks. Read all the related documents carefully before investing.

Any act of copying, reproducing, or distributing the content whether wholly or in part, for any purpose without the permission of DSIJ is strictly prohibited and shall be deemed to be copyright infringement.

Disclosures | Terms & Conditions | Privacy Statement | WhiteList
Menu
For Investor
For Trader
Advisory Service
Insight
Markets
More